MedTech Terms
    The authoritative reference
    All terms

    Performance Study Application (IVDR)

    Formal submission via EUDAMED required before commencing certain performance studies under IVDR Annex XIII and XIV.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed July 25, 2026

    Definition

    Article 58 and Annex XIV set out the application procedure for performance studies. Interventional clinical performance studies, studies involving invasive sample-taking done only for the purpose of the study, and studies of companion diagnostics using leftover samples with additional testing must be authorised by the competent authorities of the Member States in which the study is conducted. Applications are submitted through EUDAMED using a single identification number (SIN).
    What the regulation says
    Article 66 defines the substantive assessment procedure and timelines; Article 70 governs substantial modifications to authorised studies.

    What this means in practice

    The IVDR harmonises the performance-study route across Member States, replacing the fragmented national procedures of the IVDD era. Timelines mirror MDR clinical investigations: 10 days for validation, then 45 days (extendable) for substantive review.
    Grouped by theme
    Cited by

    Where this term appears across MedTech Terms.

    Primary references

    3 sources
    Link health: 2 verified 1 unchecked· last checked 2026-06-20
    EUR-Lex·1MDCG·1European Commission·1
    1. 1
      Regulation (EU) 2017/746, Articles 58 and 66
      Verified
      EUR-Lexeur-lex.europa.eu
    2. 2
      MDCG 2022-19 Performance Study Application
      Unchecked
      MDCGhealth.ec.europa.eu
    3. 3
      European Commission - Medical Devices
      Verified
      European Commissionhealth.ec.europa.eu

    Inline markers like [1] jump to the matching reference above.